Jason M. Meggs - 06 Jul 2021 Form 4 Insider Report for Syneos Health, Inc.

Role
Chief Financial Officer
Signature
/s/ Sara Epstein, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
06 Jul 2021
Net transactions value
-$29,154
Form type
4
Filing time
07 Jul 2021, 17:08:00 UTC
Previous filing
02 Jul 2021
Next filing
03 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYNH Class A Common Stock Options Exercise $1,726 +40 +0.07% $43.16 60,741 06 Jul 2021 Direct F1
transaction SYNH Class A Common Stock Sale $3,600 -40 -0.07% $90.00 60,701 06 Jul 2021 Direct F1
transaction SYNH Class A Common Stock Options Exercise $28,520 +620 +1% $46.00 61,321 06 Jul 2021 Direct F1
transaction SYNH Class A Common Stock Sale $55,800 -620 -1% $90.00 60,701 06 Jul 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SYNH Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -620 -100% $0.000000* 0 06 Jul 2021 Class A Common Stock 620 $46.00 Direct F2
transaction SYNH Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -40 -100% $0.000000* 0 06 Jul 2021 Class A Common Stock 40 $43.16 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.
F2 The shares subject to this option vested in four approximately equal annual installments on November 1, 2017; November 1, 2018; November 1, 2019; and November 1, 2020.
F3 The shares subject to this option vested in four approximately equal annual installments on July 29, 2016; July 29, 2017; July 29, 2018; and July 29, 2019.